arrow
G

Gregory S. Day

Mayo Clinic
H指数:41
被引数:8,303

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimized plasma p‐tau217 and p‐tau217/Aβ42 cutoffs enhance detection of pre‐clinical Alzheimer's disease across diverse participants

优化血浆p-tau217和p-tau217/Aβ42截断值以提高对多样化参与者中前临床阿尔茨海默病的检测

2026-08-190
OA
Early Recognition of Treatment-Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score

治疗反应性快速进行性痴呆的早期识别:改良STAM3mP评分

2026-05-270
OAAI
Distinct tau PET dynamics in early versus late age-of-onset Alzheimer’s disease

早期与晚期发病阿尔茨海默病中tau PET动态的差异

2026-01-010
OAAI
Cortical asymmetry in autosomal dominant Alzheimer's disease progression

常染色体显性阿尔茨海默病进展中的皮质不对称

2026-01-010
PRE
Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease

基于平板电脑的认知评估工具(TabCAT)在多中心早期阿尔茨海默病研究中的应用

2025-12-150
OAAI
Associations of lifestyle factors with amyloid pathology in persons without dementia

生活方式因素与无痴呆人群淀粉样蛋白病理的相关性

2025-11-130
OA
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

常染色体显性遗传性阿尔茨海默病中淀粉样蛋白慢性程度与EYO的比较

2025-10-250
OAAI
Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease

连接性作为非典型阿尔茨海默病中tau进展的通用预测因子。

BRAIN
IF11.7
2025-10-012
PRE
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

可溶性tau物种与阿尔茨海默病淀粉样斑块清除及tau病理的关系

2025-09-230
OAAI
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease

横断面FDG在唐氏综合征和常染色体显性阿尔茨海默病中的应用

2025-09-220
PRE
Quality of life over time after new onset refractory status epilepticus

新发难治性癫痫持续状态后的生活质量随时间变化

2025-09-130
OAAI
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis

细胞因子、趋化因子和神经丝轻链特征在LGI1自身免疫性脑炎中的表现

2025-08-080
OAAI
Novel set of plasma proteins classifies Alzheimer's dementia in African American individuals with high accuracy

新型血浆蛋白组对非裔美国人阿尔茨海默病痴呆具有高精度分类能力

2025-07-280
OA
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

gantenerumab在DIAN-TU-001试验中对神经影像生物标志物的区域性影响

2025-07-140
OA